Hepatitis B vaccines and uses of the same
Inventors
Brough, Douglas E. • BOLINGER, Cheryl G. • Yarlagadda, Ramya • KURELLA, Vinodhbabu • Ponraj, Prabakaran • METENOU, Simon • Ding, Kuan-Fu
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Provided herein are engineered hepatitis B virus (HBV) molecular vaccine constructs. Vaccine constructs can also include ligand-inducible engineered gene switch systems for modulating expression of heterologous genes, such as a cytokines, in host cells.
Core Innovation
The disclosure relates to polypeptide constructs and polynucleotide-encoded embodiments for hepatitis B virus (HBV)-associated antigen elements. In particular, a polypeptide construct includes an HBV Pol domain and at least one additional HBV domain selected from an HBV Envelope domain, an HBV Core domain, and an HBx domain, or alternatively an ankyrin-like repeat domain together with an HBV polypeptide.
The document further describes regulated expression using a gene switch system, including an ecdysone receptor (EcR), together with compound exposure to modulate expression. The controlled expression concepts are presented in connection with polynucleotide constructs encoding the described polypeptide constructs in cells, and the disclosure also includes multi-gene expression arrangements using internal ribosome entry site (IRES) elements.
In the vaccine context, the disclosure describes cytokine co-expression and/or administration, including interleukins and interferons, and specifically IL-12 co-delivery with HBV recombinant vaccine antigens. The described delivery platform includes a gorilla adenovector (GC46) system, with linker arrangements including polynucleotide and polypeptide linkers that are cleavable linkers and ribosome skipping 2A variants, as well as furinlink and other linker types.
Claims Coverage
The independent claim coverage includes three inventive features drawn from the provided claim text.
HBV Pol domain with additional HBV domains or ankyrin-like repeat domain
A polypeptide construct comprising an HBV Pol domain and at least one additional domain selected from an HBV Envelope domain, an HBV Core domain, and an HBx domain; or an ankyrin-like repeat domain and an HBV polypeptide.
Regulated expression by gene switch with compound exposure
A method that regulates expression of a polypeptide construct in a cell by introducing a polynucleotide construct encoding it and exposing the cell to a compound in an amount sufficient to modulate that expression.
Gorilla adenoviral vector delivery of polynucleotide constructs
A vector embodiment specified as a gorilla adenoviral vector.
The central inventive coverage is the design of HBV polypeptide constructs that either pair an HBV Pol domain with additional HBV domains or combine an ankyrin-like repeat domain with an HBV polypeptide, together with regulated expression of these constructs in cells using a gene switch system and compound exposure, with an embodiment including a gorilla adenoviral vector.
Stated Advantages
Documented Applications
No documented applications found
Interested in licensing this patent?